The clinical potential of PDL-1 pathway and some related micro-RNAs as promising diagnostic markers for breast cancer
The PB levels of PDL-1, CTLA-4, PD-1, FOXP3, MIC-B, miR-155, and miR-195 could be used as promising diagnostic markers for BC patients.
Authors
- Heba Effat (ORCID: https://orcid.org/0000-0003-2665-5681)
- Mona S. Abdellateif (ORCID: https://orcid.org/0000-0002-5510-4435)
- Motawa E. El-Houseini (ORCID: https://orcid.org/0000-0003-4873-8429)
- Sherif Ibrahim (ORCID: https://orcid.org/0000-0001-6403-7345)
- Eman A. Al-Sharabass
Institutions
- Cairo University (EG)
Publication Details
- Journal
- Molecular Medicine
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1186/s10020-025-01137-1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cairo University